FDLI panelists: Some at FDA believe agency’s hands not tied by lack of authorizing statutes
Media Mention: BioWorld ($)
This site uses cookies for performance, site traffic analysis, and social media purposes. Find out more about our cookie policy here. You can adjust your preferences in cookie settings.
